Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The ViVEXX Carotid Revascularization Trial (VIVA) for High Surgical Risk Patients With Extracranial Carotid Artery Stenosis Using the Bard ViVEXX Carotid Stent and Emboshield BareWire Rapid Exchange Embolic Protection System

NCT00417963 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.

NCT NCT00417963
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00417963 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The ViVEXX Carotid Revascularization Trial (VIVA) for High Surgical Risk Patients With Extracranial Carotid Artery Stenosis Using the Bard ViVEXX Carotid Stent and Emboshield BareWire Rapid Exchange Embolic Protection System
Lead sponsor
C. R. Bard
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2005
Completion date
March 31, 2010
Enrollment
407 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

carotid artery stenosis